ACTRN12626000854336进行中（未招募）2/3 期
CYBERABILITY: Evaluating the Smooth Sailing After Scams adjustment program addressing levels of distress in cyberscam survivors.
适应症
试验速览
- 阶段
- 2/3 期
- 状态
- 进行中（未招募）
- 入组人数
- 92
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Other
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 No limit（—）
- 性别
- All
入选标准
- •Cyberscam survivors
- •o 18 years of age or older
- •o Experienced at least one cyberscam or have been told they have experienced at least one cyberscam
- •o Experiencing adjustment and mood difficulty after being scammed based on intake interview, as the intervention specifically targets psychosocial adjustment related to a cyberscam
- •o People with and without disabilities. Disabilities include neurodevelopmental conditions such as intellectual disability, autism, attention deficit hyperactivity disorder; as well as acquired cognitive disabilities such as acquired brain injury, dementias, etc. For individuals with disability: have sufficient cognitive capacity to understand plain language explanatory statement, provide informed consent, engage in therapy tasks and complete questionnaires
- •Close others
- •o 18 years of age or older
- •o A relative, friend or support person (e.g., clinician, support worker) of a cyberscam survivor participating in this study.
排除标准
- •Cyberscam survivors
- •o Current significant psychiatric disorder, alcohol and/or drug use, measured as Level 3 – moderate on items 3, 6, 7 and 8 of the Health of Nation Outcome Scales (HoNOS) unrelated to the scam
- •o Live outside of Australia
研究者
相似试验
招募中
1 期
Safety, Tolerability and Efficacy against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve AdultsMalaria2024-518273-34-02Universitaetsklinikum Tuebingen AöR42
招募中
1 期
A Study to Test How Safe, Effective and How Body’s Responds to the Combination of Mosunetuzumab and Pirtobrutinib Together to Treat Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia2024-514152-32-00F. Hoffmann-La Roche AG22
进行中（未招募）
不适用
Development of Pain and Disability scale in patients with Lumbar PIVDCTRI/2026/07/113948Sanam Maurya51
已完成
1 期
Characterisation of availability in the body of the active substance(s) of the newly developed patch Esflurbiprofen Topical System (EFTS) in comparison with a marketed oral flurbiprofen-containing tablet formulation after multiple dose administration including adhesion assessment of the patch - a phase I, open-label, randomised, 2-period, cross-over study in healthy subjects2024-513058-31-00Teikoku Seiyaku Co. Ltd.26
进行中（未招募）
不适用
Examining the Feasibility of CBT using a Smartphone Application for PPPDPersistent postural-perceptual dizzinessjRCT103226009770